Skip to main content
Clinical Trials/NL-OMON34134
NL-OMON34134
Withdrawn
Phase 4

Prevalence of Psoriatic Arthritis in Adults with Psoriasis: An Estimate From Dermatology Practice - PsA prevalence study

Pfizer0 sites20 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Psoriasis
Sponsor
Pfizer
Enrollment
20
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Pfizer

Eligibility Criteria

Inclusion Criteria

  • 1\. Subject has a confirmed diagnosis of plaque psoriasis by clinical judgement.
  • 2\. Subject is \>18 years of age at the time of consent.
  • 3\. Subject is able to read and complete questionnaires.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials